The NeuroPointDX Autism Spectrum Disorder (NPDX ASD) Blood Test
Autism spectrum disorder (ASD) is highly heritable, heterogeneous, and among the most prevalent neurodevelopmental disorders, affecting ~2% of U.S. children. Clinical features include challenges in social communication and interaction, restricted interests, repetitive behaviors, and attention difficulties. Diagnosis has traditionally relied on behavioral assessments, but biological tools are emerging to complement clinical evaluation.
The NeuroPointDX ASD Blood Test analyzes specific biomarkers that serve as molecular signatures associated with ASD. The test includes two metabolomic panels:1) Amine Panel: 32 amino acid and amine metabolites, and 2) Energy Panel: 16 metabolites reflecting mitochondrial, microbiome, and energy metabolism.
These results are compared against validated ASD-associated metabolic profiles from the Children’s Autism Metabolome Project (CAMP), involving over 1,100 children. A proprietary algorithm classifies ASD-associated metabotypes and provides a positive/negative overall result with interpretation of metabolic imbalances. The test is non-invasive and offers potential for earlier detection of ASD, though it is not a standalone diagnostic and requires comprehensive clinical evaluations.
- Early diagnosis and monitoring of autism spectrum disorders
- Provides metabolic insights to guide individualized care, interventions, and therapy planning
Positive Result:
- Indicates a metabolic imbalance consistent with ASD-associated metabotypes, suggesting higher likelihood of ASD and supports referral for early intervention and specialist evaluation
Negative Result:
- Does not rule out ASD, as ~28% of ASD cases may not be detected by this test.
Reported as Positive or Negative relative to algorithm-defined thresholds
Whole blood, EDTA.
Stability
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: 20 days
- Nat Rev Dis Primers. 2020 Jan 16;6(1):5. [PMID: 31949163]
- Int J Mol Sci. 2023 Apr 18;24(8):7443. [PMID: 37108604]
- Mol Diagn Ther. 2022 Sep;26(5):483-495. [PMID: 35759118]
- Biol Psychiatry. 2018;85(4):345-354. [PMID: 30446206]
- Autism Res. 2020;13(8):1270-1285. [PMID: 32558271]